Optimal dual calcium and cholecalciderol dosages for osteoporotic fracture risk patients

Khaled Mohammad Juma Husain Bani Hani 1, *, Sinan Ibrahim Alghamaz 1, Madher Ali Mohammad Doumi 1, Rami Mohamad Salem Aldarawshe 1, Suhib Fayiz Naim Dawaghreh 1, Ahmed Mahmoud Mohammed Ali Alboun 2 and Kholoud Muhsen Al Quraan 3

1 Rehabilitation and rheumatology specialist, Royal Medical Services, Jordan.
2 Registered Nurse, Royal Medical Services, Jordan.
3 Lab Technician, Royal Medical Services, Jordan.
 
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2024, 17(03), 205–220.
Article DOI: 10.30574/wjbphs.2024.17.3.0120
 
Publication history: 
Received on 01 March 2024; revised on 20 March 2024; accepted on 22 March 2024
 
Abstract: 
Background: Vitamin D is crucial for musculoskeletal health, promoting calcium absorption, osteoid tissue mineralization, and muscle function. Insufficient levels can lead to bone dystrophy, muscle weakness, and osteoporotic fractures.
Aims: This research investigates the correlation between bone mineral density and osteoporotic fracture risk, including positive and negative influences, and aims to determine the optimal vitamin D level.
Methods: This retrospective observational study examined 206 Jordanian rehabilitation and rheumatology clinic patients from September to November 2021. The participants were post-menopausal women and men over 60. The Age-adjusted Charlson Co-Morbidity Index and Functionality Grade system was used to assess participants' co-morbidity burden and functionality. DEXA scans assessed participants' proximal femoral hip and anteroposterior spine. Participants were divided into two Vit D groups: those below 30 ng/ml and those above 30. Results were compared using a Chi Square test. The study examined correlations, total variations, and Vit D prediction quality using logistic regression analyses. SPSS 23.0 was used for statistical analysis with a 5% significance level.
Results: A binary logistic regression model was employed to simulate the correlation between the vitamin D levels of patients and their bone mineral density. The model indicated a 61.39% likelihood of having a fH_BMD (femoral head bone mineral density) equal to or greater than 0.755 g/cm2 when the vitamin D level is at its optimal value of 27.25 ng/ml. The model indicated a 27.25% likelihood of a fHOPF risk-free tool with a value of ≥3% when the optimal vitamin D level is 27.25 ng/ml. The model indicated a 17.74% likelihood of experiencing a significant osteoporotic fracture within the next 10 years.
Conclusion: The findings of our study demonstrated a direct correlation between elevated levels of vitamin D and improved bone mineral quality indices that were examined. The serum 25-OH Cholecalciferol levels are more likely to have a beneficial effect on bone health status.
 
Keywords: 
Bisphosphonate; Vertebral fracture; Non-Vertebral fracture; Optimal threshold; Osteoporosis
 
Full text article in PDF: